CLINICAL_TRIALS trial_result · 2016-06-27

Clinical Trial Update: Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease [Phase 4]

Phase 4 trial evaluating safety and efficacy of donepezil HCl 23 mg in moderate to severe Alzheimer's disease; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eisai Korea Inc. | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED | Results posted: 2016-06-27